Spotlight
Circulating Tumor DNA IDs Relapse Risk in Early NSCLC
Jun 14, 2022
The identification of circulating tumor DNA (ctDNA) following initial treatment among patients...
Read More#VisualAbstract: Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer
May 19, 2022
1. Patients who underwent segmentectomy reported a significantly greater 5-year overall survival...
Read MoreAdverse Pregnancy Outcomes & Incident Heart Failure
Apr 18, 2022
Women with a history of hypertensive disorders of pregnancy should be monitored so that preventive...
Read MoreHeart Failure Outcomes After Discharge to SNFs With Delirium
Apr 12, 2022
Patients with HF who developed delirium were more likely to die within 30 days...
Read MoreAcross Gynecologic Cancer Risk Groups, SLN Biopsy Deemed Effective
Mar 30, 2022
Sentinel lymph node (SLN) biopsy can be regularly used in surgical staging among high-risk...
Read MoreRN-VT Outcomes for Patients With Renal Cell Carcinoma
Mar 30, 2022
Following radical nephrectomy and venous thrombectomy (RN-VT), patients with renal cell carcinoma...
Read MoreMetastatic Renal Cell Carcinoma Outcomes Linked With CT Texture Analysis
Mar 30, 2022
In metastatic renal cell carcinoma (mRCC), immune checkpoint inhibitor treatment responses vary,...
Read MoreGynecologic Cancer Survival Impacted By Race
Mar 15, 2022
Across histologies other than clear cell, Black women with stage 1 endometrial cancer experienced...
Read MoreRenal Cell Carcinoma & Deep Invasive Tumor Thrombus: Predicting Surgical Complications
Mar 8, 2022
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read MoreTake Our Growth Hormone Deficiency Quiz!
Mar 2, 2022
Test your growth hormone deficiency knowledge.
Read MoreSub-Lobar Resection Good For Geriatric Patients With eNSCLC
Feb 25, 2022
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read MorePreoperative PET/CT Predicts Uterine Tumor Characteristics
Feb 11, 2022
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Read MoreAssessing Telehealth for the Outpatient Management of Heart Failure
Feb 8, 2022
The burden of stay-at-home mandates resulting from COVID-19 and the hesitancy of people to leave...
Read MoreConstruction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
Feb 7, 2022
In this study, bioinformatics methods were performed to screen the candidate prognosis-related...
Read MoreAberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer
Feb 3, 2022
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids...
Read MorePembrolizumab Bests TKIs for Treating High-Risk Renal Cell Carcinoma
Feb 1, 2022
A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...
Read More